Evaluation of dermato-pharmacokinetics after repeated application of lanoconazole -whole day application 5days repeated trial-

Evaluation of dermato-pharmacokinetics after repeated application of lanoconazole -whole day application 5days repeated trial- - Evaluation of dermato-pharmacokinetics after repeated application of lanoconazole

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019856

Enrollment

Registered

2015-11-20

Start date

2016-01-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteer

Interventions

external administration of lanoconazole cream dose: 350mg on the 1st day with gradual decrease five days repeated administration

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: BMI >=17.5, <30.0

Exclusion criteria

Exclusion criteria: *any skin abnormality *any drug, cosmetics, or food allergy *any abnormal findings in the following items, hematology, biochemistry, urinalysis, blood pressure, ECG, and clinical examination

Design outcomes

Primary

Measure	Time frame
pharmacokinetic parameters of lanoconazole in stratum corneum (time of assessment: within 3 months after completion of drug administration)	—

Countries

Japan

Contacts

Public ContactHiromitsu Imai

Oita university Faculty of medicine Dept of clinical pharmacology and therapeutics

imaih@oita-u.ac.jp097-586-5952

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026